These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 37946674)

  • 41. Engineering and physical sciences in oncology: challenges and opportunities.
    Mitchell MJ; Jain RK; Langer R
    Nat Rev Cancer; 2017 Nov; 17(11):659-675. PubMed ID: 29026204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening.
    Brooks A; Zhang Y; Chen J; Zhao CX
    Adv Healthc Mater; 2024 Aug; 13(21):e2302436. PubMed ID: 38224141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?
    Clara-Trujillo S; Gallego Ferrer G; Gómez Ribelles JL
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.
    Rothbauer M; Rosser JM; Zirath H; Ertl P
    Curr Opin Biotechnol; 2019 Feb; 55():81-86. PubMed ID: 30189349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.
    Gu L; Mooney DJ
    Nat Rev Cancer; 2016 Jan; 16(1):56-66. PubMed ID: 26694936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advancing Tumor Microenvironment Research by Combining Organs-on-Chips and Biosensors.
    Calejo I; Heinrich MA; Zambito G; Mezzanotte L; Prakash J; Moreira Teixeira L
    Adv Exp Med Biol; 2022; 1379():171-203. PubMed ID: 35760992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review.
    Xu H; Cheng C; Le W
    Electrophoresis; 2022 Apr; 43(7-8):839-847. PubMed ID: 35179796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of tumor organoids and their application to cancer research and therapy.
    Lv J; Du X; Wang M; Su J; Wei Y; Xu C
    Theranostics; 2024; 14(3):1101-1125. PubMed ID: 38250041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reconstructing the tumor architecture into organoids.
    Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
    Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
    Xing H; Li X
    Chemistry; 2024 Jun; 30(32):e202400425. PubMed ID: 38576219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New Endeavors of (Micro)Tissue Engineering: Cells Tissues Organs on-Chip and Communication Thereof.
    Ahmed HMMAM; Moreira Teixeira LS
    Cells Tissues Organs; 2022; 211(6):721-735. PubMed ID: 34198305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organ-on-a-chip technology for the study of the female reproductive system.
    Young RE; Huh DD
    Adv Drug Deliv Rev; 2021 Jun; 173():461-478. PubMed ID: 33831478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiscale tissue engineering for liver reconstruction.
    Sudo R
    Organogenesis; 2014; 10(2):216-24. PubMed ID: 24500493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineering strategies to mimic the glioblastoma microenvironment.
    Rape A; Ananthanarayanan B; Kumar S
    Adv Drug Deliv Rev; 2014 Dec; 79-80():172-83. PubMed ID: 25174308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineering complexity in human tissue models of cancer.
    Ronaldson-Bouchard K; Baldassarri I; Tavakol DN; Graney PL; Samaritano M; Cimetta E; Vunjak-Novakovic G
    Adv Drug Deliv Rev; 2022 May; 184():114181. PubMed ID: 35278521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction to bioprinting of in vitro cancer models.
    Yi HG
    Essays Biochem; 2021 Aug; 65(3):603-610. PubMed ID: 34028520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanotechnology meets 3D in vitro models: tissue engineered tumors and cancer therapies.
    da Rocha EL; Porto LM; Rambo CR
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():270-9. PubMed ID: 24268259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microfluidic bioprinting for organ-on-a-chip models.
    Yu F; Choudhury D
    Drug Discov Today; 2019 Jun; 24(6):1248-1257. PubMed ID: 30940562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
    Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
    Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heralding a new paradigm in 3D tumor modeling.
    Fong EL; Harrington DA; Farach-Carson MC; Yu H
    Biomaterials; 2016 Nov; 108():197-213. PubMed ID: 27639438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.